TD Asset Management’s Insmed INSM Stock Holding History

TD Asset Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.6M	Buy	240,182 +76,758	+47%	+$9.29M	0.02%	453
2026 Q1	$26.7M	Sell	163,424 -99,054	-38%	-$15.2M	0.02%	456
2025 Q4	$45.7M	Sell	262,478 -135,778	-34%	-$24.8M	0.04%	335
2025 Q3	$57.4M	Buy	398,256 +3,062	+0.8%	+$375K	0.05%	292
2025 Q2	$39.8M	Sell	395,194 -107,038	-21%	-$8.18M	0.03%	371
2025 Q1	$38.3M	Sell	502,232 -24,658	-5%	-$1.89M	0.04%	370
2024 Q4	$36.4M	Buy	526,890 +13,808	+3%	+$994K	0.03%	381
2024 Q3	$37.2M	Sell	513,082 -12,600	-2%	-$930K	0.03%	361
2024 Q2	$35.2M	Buy	525,682 +98,504	+23%	+$3.82M	0.03%	351
2024 Q1	$11.6M	Sell	427,178 -36,354	-8%	-$1.02M	0.01%	604
2023 Q4	$14.4M	Sell	463,532 -59,600	-11%	-$1.55M	0.01%	552
2023 Q3	$13.2M	Buy	523,132 +194,145	+59%	+$4.44M	0.02%	528
2023 Q2	$6.94M	Sell	328,987 -15,930	-5%	-$302K	0.01%	673
2023 Q1	$5.88M	Sell	344,917 -3,263	-0.9%	-$63.4K	0.01%	709
2022 Q4	$6.96M	Buy	348,180 +2,811	+0.8%	+$54.3K	0.01%	670
2022 Q3	$7.55M	Sell	345,369 -6,640	-2%	-$159K	0.01%	657
2022 Q2	$6.94M	Sell	352,009 -4,977	-1%	-$104K	0.01%	699
2022 Q1	$8.39M	Sell	356,986 -31,976	-8%	-$743K	0.01%	700
2021 Q4	$10.6M	Buy	388,962 +114,230	+42%	+$3.27M	0.01%	667
2021 Q3	$7.57M	Sell	274,732 -5,496	-2%	-$144K	0.01%	717
2021 Q2	$6.89M	Buy	280,228 +29,364	+12%	+$871K	0.01%	748
2021 Q1	$8.54M	Buy	250,864 +52,626	+27%	+$2.01M	0.01%	679
2020 Q4	$6.6M	Buy	198,238 +17,216	+10%	+$629K	0.01%	717
2020 Q3	$5.82M	Sell	181,022 -3,000	-2%	-$86.2K	0.01%	663
2020 Q2	$5.07M	Buy	184,022 +70,027	+61%	+$1.66M	0.01%	654
2020 Q1	$1.83M	Buy	113,995 +3,300	+3%	+$78.2K	﹤0.01%	856
2019 Q4	$2.64M	Sell	110,695 -10,900	-9%	-$222K	﹤0.01%	866
2019 Q3	$2.15M	Sell	121,595 -5,751	-5%	-$111K	﹤0.01%	895
2019 Q2	$3.26M	Sell	127,346 -32,600	-20%	-$908K	﹤0.01%	797
2019 Q1	$4.65M	Sell	159,946 -21,900	-12%	-$568K	0.01%	711
2018 Q4	$2.39M	Sell	181,846 -55,700	-23%	-$889K	﹤0.01%	869
2018 Q3	$4.8M	Sell	237,546 -28,149	-11%	-$636K	0.01%	741
2018 Q2	$6.28M	Buy	265,695 +5,800	+2%	+$149K	0.01%	637
2018 Q1	$5.85M	Sell	259,895 -900	-0.3%	-$23.7K	0.01%	638
2017 Q4	$8.13M	Sell	260,795 -100	-0%	-$2.95K	0.01%	569
2017 Q3	$8.14M	Buy	260,895 +36,145	+16%	+$688K	0.01%	555
2017 Q2	$3.86M	Sell	224,750 -17,813	-7%	-$304K	0.01%	733
2017 Q1	$4.25M	Sell	242,563 -3,137	-1%	-$48.4K	0.01%	721
2016 Q4	$3.25M	Buy	245,700 +2,800	+1%	+$38.2K	0.01%	765
2016 Q3	$3.53M	Buy	242,900 +4,500	+2%	+$56.3K	0.01%	769
2016 Q2	$2.35M	Buy	238,400 +9,300	+4%	+$109K	﹤0.01%	832
2016 Q1	$2.9M	Sell	229,100 -3,900	-2%	-$51.3K	0.01%	784
2015 Q4	$4.23M	Sell	233,000 -1,500	-0.6%	-$26.4K	0.01%	711
2015 Q3	$4.36M	Buy	234,500 +21,600	+10%	+$539K	0.01%	673
2015 Q2	$5.2M	Buy	212,900 +120,800	+131%	+$2.74M	0.01%	662
2015 Q1	$1.92M	Buy	92,100 +75,900	+469%	+$1.34M	﹤0.01%	840
2014 Q4	$251K	Buy	16,200 +700	+5%	+$9.93K	﹤0.01%	1281
2014 Q3	$202K	Buy	+15,500	New	+$234K	﹤0.01%	1253

Other funds holding INSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TD Asset Management's INSM Position: Q2 2026 in Review

TD Asset Management increased its Insmed (INSM) stake by 47% in Q2 2026, buying an estimated $9.29M and bringing the position to 240,182 shares worth $25.6M. The position accounts for 0.02% of the portfolio, ranked #453.

TD Asset Management first reported a position in INSM in Q3 2014 and has held it in 48 quarters since. The position peaked at $57.4M in Q3 2025. 462 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

TD Asset Management held 240,182 shares of Insmed worth $25.6M as of Q2 2026.
TD Asset Management bought 76,758 Insmed shares in Q2 2026, an estimated $9.29M.
Insmed made up 0.02% of TD Asset Management's portfolio in Q2 2026, its #453 holding.
TD Asset Management first reported a position in Insmed in Q3 2014 and has held it in 48 quarters since.
TD Asset Management's Insmed position peaked at $57.4M in Q3 2025.
462 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.